Loading ETF profile…
The ALPS Medical Breakthroughs ETF (SBIO) is designed to largely mirror the investment returns of its reference benchmark, the S-Network Medical Breakthroughs Index (PMBI). This objective is pursued before accounting for any associated fees and operational costs.
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| APGE | Apogee Therapeutics Inc. | 4.37% | $8.22M |
| CGON | CG oncology Inc. | 3.47% | $6.52M |
| XENE | Xenon Pharmaceuticals Inc. | 3.09% | $5.82M |
| ORKA | Oruka Therapeutics Inc. | 2.97% | $5.60M |
| TVTX | Travere Therapeutics Inc. | 2.89% | $5.43M |
| DNTH | Dianthus Therapeutics Inc. | 2.79% | $5.24M |
| MANE | VeraDermics Inc. | 2.75% | $5.17M |
| DFTX | Definium Therapeutics Inc. | 2.71% | $5.10M |
| EWTX | Edgewise Therapeutics Inc. | 2.35% | $4.41M |
| ACAD | ACADIA Pharmaceuticals Inc. | 2.29% | $4.32M |
| RLAY | Relay Therapeutics Inc. | 2.29% | $4.31M |
| DNLI | Denali Therapeutics Inc. | 2.19% | $4.12M |
| NAMS | Newamsterdam Pharma Co. NV | 2.11% | $3.97M |
| CRNX | Crinetics Pharmaceuticals Inc. | 2.07% | $3.90M |
| GPCR | Structure Therapeutics Inc. | 1.96% | $3.68M |
| DYN | Dyne Therapeutics Inc. | 1.87% | $3.52M |
| IDYA | Ideaya Biosciences Inc. | 1.71% | $3.22M |
| VERA | Vera Therapeutics Inc. | 1.65% | $3.10M |
| CLDX | Celldex Therapeutics Inc. | 1.56% | $2.94M |
| SLS | SELLAS Life Sciences Group Inc. | 1.53% | $2.88M |
| IRON | Disc Medicine Inc. | 1.51% | $2.85M |
| KLRA | Kailera Therapeutics Inc. | 1.50% | $2.81M |
| TARS | Tarsus Pharmaceuticals Inc. | 1.40% | $2.63M |
| MBX | MBX Biosciences Inc. | 1.36% | $2.56M |
| BCRX | BioCryst Pharmaceuticals Inc. | 1.29% | $2.43M |